Viewing nowCombinationEmpagrom 12.5/1000 milligram (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 202501915 · Approved 2025.07.25 · Insurance code 645307230
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps control blood sugar in patients with type 2 diabetes through the combined administration of empagliflozin and metformin. It can be used effectively in conjunction with diet and exercise to manage blood sugar. Particularly in type 2 diabetes patients whose blood sugar is not sufficiently controlled and have cardiovascular diseases, it may help reduce the risk of cardiovascular events. Therefore, positive effects on blood sugar control and cardiovascular health management can be expected with this medication.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, sections 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you forget to take this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, section 3. Patients Requiring Caution, subsection 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, section 2. Patients Who Must Not Use This Medicine, subsection 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used to help control blood sugar and is mainly used in diabetes treatment. Rare side effects can include severe lactic acidosis, so patients with poor kidney function or liver problems should be cautious when taking this medication. Additionally, there is a risk of hypoglycemia when taken with insulin or sulfonylurea medications, so dosages should be adjusted according to the doctor's instructions. Patients with moderate to severe kidney function impairment, acute infections, dehydration, heart failure, and those around the time of surgery should not take this medication. Use of iodine contrast agents should also lead to a temporary pause in this medication, which should only be resumed after kidney function returns to normal. This medication can increase the risk of urinary tract infections and genital infections, so consult a doctor immediately if infection symptoms occur. Long-term use may lower vitamin B12 levels, thus regular blood tests to monitor the condition are recommended. Pregnant or breastfeeding women are advised to avoid taking this medication, and it is not recommended for children or adolescents under 18. Older adults or patients at risk of fluid loss should be cautious for dehydration or low blood pressure, and kidney function tests should be performed regularly. Overdose can cause serious side effects such as lactic acidosis, so dosage must be strictly followed, and if unusual symptoms occur, a medical facility should be visited immediately. Avoid alcohol during this medication, and be careful of the risk of hypoglycemia during irregular meals or intense physical activity. The effects on driving or operating machinery are unclear, but caution is needed if dizziness or hypoglycemic symptoms occur. This medication may interact with other medications, so inform healthcare providers of any other medications being taken. Finally, store out of reach of children and keep in the original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 degree to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety for a longer period.
Biconvex oval film-coated tablet with a dark brownish purple color
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.